Routine governance disclosure — no trading signal. Monitor future filings for any material changes in board composition or financial performance.
Price Chart
Executive Summary
Mobia Medical filed two 8-K/A amendments on October 16, 2026, each supplementing prior Item 5.02 reports to disclose committee appointments. The first appoints Myriam J. Curet, M.D. to the nominating and corporate governance committee; the second appoints Reza Zadno, Ph.D. to the audit committee (he continues on the compensation committee). Both appointments were effective October 15, 2026. These are routine governance updates with no financial impact.
Key Facts
- Two 8-K/A amendments filed on October 16, 2026, each reporting a single committee appointment effective October 15, 2026.
- Myriam J. Curet, M.D. appointed to the nominating and corporate governance committee.
- Reza Zadno, Ph.D. appointed to the audit committee; he continues serving on the compensation committee.
- Both amendments state that all other disclosures in the original 8-K filings remain unchanged.
Financial Impact
No financial figures disclosed; no material impact.
Risk Factors
- No material risks identified from these filings.
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K/A Filing (MOBI) — Batch item 1 | 0001193125-26-424158 |
| Document: 0001193125-26-424158-index-headers.html | 0001193125-26-424150 |
| Document: 0001193125-26-424158-index.html | 0001193125-26-424158 |
| Document: 0001193125-26-424158.txt | 0001193125-26-424158 |
| 8-K/A Filing (MOBI) — Batch item 5 | 0001193125-26-424150 |
| Document: 0001193125-26-424150-index-headers.html | 0001193125-26-424158 |
| Document: 0001193125-26-424150-index.html | 0001193125-26-424158 |
| Document: 0001193125-26-424150.txt | 0001193125-26-424158 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K/A | $8.81 | awaiting T+60 | — | $10.73 (+21.79%) |
Oct 15, 2026 12d ago | Press Release | $8.09 | awaiting T+60 | — | $10.73 (+32.63%) |
Aug 20, 2026 9w ago | Insider Buy | $10.61 | awaiting T+60 | — | $10.73 (+1.13%) |
Aug 17, 2026 10w ago | Insider Buy | $11.73 | awaiting T+60 | — | $10.73 (−8.53%) |
Jun 29, 2026 17w ago | Insider Cluster | $13.40 $9.16 | ▼ −31.64% | ▼ −34.46% | $10.73 (−19.93%) |
Jun 11, 2026 19w ago | Insider Buy | $12.31 $11.09 | ▼ −9.91% | ▼ −13.17% | $10.73 (−12.84%) |
May 11, 2026 24w ago | Insider Cluster | $12.00 $12.25 | ▲ +2.08% | ▼ −2.31% | $10.73 (−10.58%) |
May 11, 2026 24w ago | Insider Cluster | $12.00 $12.25 | ▲ +2.08% | ▼ −2.31% | $10.73 (−10.58%) |
May 8, 2026 24w ago | EFFECT | $11.75 $11.84 | ▲ +0.77% | ▼ −4.07% | $10.73 (−8.68%) |
May 7, 2026 24w ago | 3 | $11.75 $11.84 | ▲ +0.77% | ▼ −4.07% | $10.73 (−8.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers